NEUROMETRIX, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-12-29: Form 8-K; Period of report 2016-12-28; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 1.01.
- 2016-12-08: Form 8-K; Period of report 2016-12-08; Description 8.01 Other Events; Details 8.01.
- 2016-10-31: Form 8-K; Period of report 2016-10-31; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2016-10-20: Form 8-K; Period of report 2016-10-20; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2016-12-29 | 8-K | 2016-12-28 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 3.02 The shares of Series E Preferred Stock, Warrants and Placement Agent Warrants described above have not been registered under the Securities Act of 1933, as amended. 3.03 The Company filed the Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing and designating the Series E Preferred Stock. 5.03 On December 28, 2016, the Company filed the Certificate of Designation, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference. 8.01 On December 28, 2016, the Company issued a press release announcing the Offering. | v455834_8-k.htm |
| 2016-12-08 | 8-K | 2016-12-08 | 8.01 Other Events | 8.01 As of December 7, 2016, the Quell Wearable Pain Relief Technology was made available for sale on the Medtronic Diabetes e-commerce website at https://medtronicdiabetes.secure.force.com/store/health-fitness. | v454633_8k.htm |
| 2016-10-31 | 8-K | 2016-10-31 | 7.01 Regulation FD Disclosure | 7.01 On October 31, 2016, NeuroMetrix, Inc. (the “Company”) provided an update to its corporate presentation in connection with the Sidoti Emerging Growth Convention at the Marriot Marquis in New York City on November 1, 2016, by posting the presentation to the Company’s website, www.neurometrix.com. | v451803_8k.htm |
| 2016-10-20 | 8-K | 2016-10-20 | 2.02 Results of Operations and Financial Condition | 2.02 On October 20, 2016, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter and nine months ended September 30, 2016. | v450793_8k.htm |
| 2016-07-21 | 8-K | 2016-07-21 | 2.02 Results of Operations and Financial Condition | 2.02 On July 21, 2016, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2016. | v444615_8k.htm |
| 2016-06-03 | 8-K | 2016-06-02 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 3.02 The shares of Preferred Stock, Warrants and Placement Agent Warrants described above have not been registered under the Securities Act of 1933, as amended. 3.03 The Company filed the Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing and designating the Preferred Stock. 5.03 On June 3, 2016, the Company filed the Certificate of Designation, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference. 8.01 On June 2, 2016, the Company issued a press release announcing the Offering. | v441676_8k.htm |
| 2016-06-02 | 8-K | 2016-06-02 | 8.01 Other Events | 8.01 NeuroMetrix, Inc. (the “Corporation”) reported that its book value per share as of May 31, 2016 was $1.42. | v441580_8-k.htm |
| 2016-05-05 | 8-K | 2016-05-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 (e) At the NeuroMetrix, Inc. (the “Corporation”) Annual Meeting of Stockholders held on May 3, 2016 (the “Annual Meeting”), the stockholders of the Corporation approved the Corporation’s Eighth Amended and Restated 2004 Stock Option and Incentive Plan (the “2004 Stock Option and Incentive Plan”) and the Third Amended and Restated 2010 Employee Stock Purchase Plan (the “2010 Employee Stock Purchase Plan”). 5.07 (a) The Corporation’s Annual Meeting was held on May 3, 2016 at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, MA 02111. | v439089_8k.htm |
| 2016-04-21 | 8-K | 2016-04-21 | 2.02 Results of Operations and Financial Condition | 2.02 On April 21, 2016, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2016. | v437511_8k.htm |
| 2016-01-28 | 8-K | 2016-01-28 | 2.02 Results of Operations and Financial Condition | 2.02 On January 28, 2016, NeuroMetrix, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2015. | v429908_8k.htm |
| 2016-01-11 | 8-K | 2016-01-11 | 2.02 Results of Operations and Financial Condition | 2.02 On January 11, 2016, NeuroMetrix, Inc. issued a press release reporting selected preliminary financial information for the fiscal year ended December 31, 2015. | v428714_8k.htm |